IGFBP-rP1 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer

Cell Death Dis. 2015 Mar 19;6(3):e1695. doi: 10.1038/cddis.2015.59.

Abstract

Epithelial-mesenchymal transition (EMT) was initially recognized during organogenesis and has recently been reported to be involved in promoting cancer invasion and metastasis. Cooperation of transforming growth factor-β (TGF-β) and other signaling pathways, such as Ras and Wnt, is essential to inducing EMT, but the molecular mechanisms remain to be fully determined. Here, we reported that insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1), a potential tumor suppressor, controls EMT in colorectal cancer progression. We revealed the inhibitory role of IGFBP-rP1 through analyses of clinical colorectal cancer samples and various EMT and metastasis models in vitro and in vivo. Moreover, we demonstrated that IGFBP-rP1 suppresses EMT and tumor metastasis by repressing TGF-β-mediated EMT through the Smad signaling cascade. These data establish that IGFBP-rP1 functions as a suppressor of EMT and metastasis in colorectal cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Carcinogenesis*
  • Cell Movement / genetics
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • Epithelial-Mesenchymal Transition / genetics*
  • Female
  • Humans
  • Insulin-Like Growth Factor Binding Proteins / biosynthesis
  • Insulin-Like Growth Factor Binding Proteins / genetics*
  • Male
  • Mice
  • Middle Aged
  • Neoplasm Metastasis
  • Smad Proteins / genetics
  • Transforming Growth Factor beta / administration & dosage
  • Transforming Growth Factor beta / metabolism*
  • Wnt Signaling Pathway / genetics

Substances

  • Insulin-Like Growth Factor Binding Proteins
  • Smad Proteins
  • Transforming Growth Factor beta
  • insulin-like growth factor binding protein-related protein 1